amylin glp 1 dual agonist Effects, working principles and target tissues of agonists Amylin: From Mode of Action
Description
Discontinuation of GLUCAGON-like peptide-1 receptor agonists
Clinical studies have not generally documented serious side effects that require discontinuation of liraglutide, but gastrointestinal side effects, such as nausea, vomiting, and digestive disorders, often occur
J Natl Cancer Inst 117: 476485, 2025
It is approved for treating hyperglycemia in patients with T2DM in many countries (105, 106)
Drugs adopting this strategy produced body weight reduction more than 20%
